Adamas Announces New Employment Inducement Grant
07 juin 2019 17h30 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., June 07, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted five new...
Adamas to Present at Upcoming JMP Investor Conference
03 juin 2019 16h31 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous...
Adamas Pharmaceuticals Welcomes Vijay Shreedhar as Chief Commercial Officer
30 mai 2019 16h30 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous...
Adamas to Present at Upcoming BAML Investor Conference
13 mai 2019 11h14 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous...
Adamas Reports First Quarter 2019 Financial Results
09 mai 2019 16h03 HE
|
Adamas Pharmaceuticals, Inc.
- First quarter net product sales of $11.7 million - GOCOVRI® total prescriptions grew to approximately 5,820 in Q1 2019 - Phase 3 study of ADS-5102 (GOCOVRI) in walking impairment in patients with...
Adamas to Announce First Quarter 2019 Financial Results and Host Conference Call on May 9, 2019
02 mai 2019 16h05 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report 2019 first quarter financial results on Thursday, May 9,...
Adamas Announces New Employment Inducement Grant
12 mars 2019 16h05 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted four...
Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2018
04 mars 2019 16h35 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today reported recent achievements and financial results for the fourth quarter and full-year ended...
Adamas to Present at Two Upcoming Investor Conferences
20 févr. 2019 16h50 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous...
Adamas to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on March 4, 2019
20 févr. 2019 16h49 HE
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report fourth quarter and year-end 2018 financial results on...